The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.
An executive interview with Felix Hsu, Senior Vice President and Global Head at WuXi Advanced Therapies. We take a strategic look at accelerating advanced therapy pipelines and viral vector commercialisation through greater predictability
Edition two of Phacilitate’s technology review series examines the range of artificial intelligence, data management and analytics software to improve efficiencies in cell and gene therapy manufacturing. In partnership with Anemocyte.
